奥福环保(688021) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥98,127,243.94, representing a year-on-year increase of 76.59%[2] - The net profit attributable to shareholders was ¥9,039,625.45, showing a decrease of 8.94% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses was ¥8,289,703.35, with a slight decrease of 1.32% year-on-year[2] - The net profit for Q1 2023 was ¥8,539,841.79, a decrease of 11.6% from ¥9,656,097.45 in Q1 2022[18] - Basic and diluted earnings per share for Q1 2023 were both ¥0.12, down from ¥0.13 in Q1 2022[19] Cash Flow - The net cash flow from operating activities was -¥23,501,343.33, a decline of 75.84% compared to the previous year[2] - Cash flow from operating activities for Q1 2023 was negative at -¥23,501,343.33, compared to -¥13,365,142.31 in Q1 2022[20] - The company's cash and cash equivalents net increase was CNY -48,947,143.68 in Q1 2023, compared to CNY -2,773,343.29 in Q1 2022[1] - The net cash flow from investment activities was -62,154,122.70 RMB, compared to -1,699,754.01 RMB in Q1 2022, reflecting a substantial increase in cash outflow[26] - The net cash flow from financing activities was 10,369,878.17 RMB, an increase of 173.5% compared to 3,798,871.40 RMB in the same quarter last year[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,499,070,942.53, an increase of 4.05% from the end of the previous year[4] - The company's total liabilities increased to CNY 554,998,338.45 from CNY 507,861,865.51, which is an increase of about 9.26%[16] - The total equity attributable to shareholders reached CNY 932,298,896.77, up from CNY 920,623,924.07, reflecting a growth of approximately 1.73%[16] - The company's total liabilities increased to CNY 394,232,308.14 in Q1 2023, compared to CNY 313,992,568.11 in Q4 2022[22] Research and Development - Research and development expenses totaled ¥9,801,291.65, accounting for 9.99% of operating revenue, a decrease of 3.90 percentage points[4] - Research and development expenses for Q1 2023 were CNY 8,615,036.18, a significant increase from CNY 4,107,785.42 in Q1 2022[24] Inventory and Receivables - The company experienced a 131.37% increase in notes receivable, primarily due to increased sales revenue[7] - The company reported a 94.72% increase in operating costs, corresponding to the rise in sales volume[8] - Accounts receivable rose to CNY 123,308,802.79, up from CNY 84,505,348.19, marking an increase of around 46%[14] - The company reported a total inventory of CNY 303,764,407.36, slightly up from CNY 303,635,680.90, indicating a marginal increase[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 2,945[10] - The company's total owner's equity as of March 31, 2023, was CNY 939,066,016.17, up from CNY 931,331,409.77 at the end of 2022[23]